TAK-700 R-form Catalog No.:M22571-C which may lead to a

which may lead to a reduction in inflammation and an inhibition of cellular proliferation

enhancing the proliferation and function of immune competent cells) and plays important role in gap junction communication (e

JPH203 Dihydrochloride is a tyrosine analog

6(12):e27865

Glicoricone

TAK-700 R-form Catalog No.:M22571-C which may lead to aTAK 700 R form is a highly selective inhibitor of 17, 20 lyase with IC50 value of 38nM . TAK 700 is a potent and selective inhibitor of the 17, 20 lyase activity of CYP17A1 which is responsible for androgen biosynthesis. Thus, TAK 700 is selected as a candidate for treatment of prostate cancer through reducing the adrenal androgen production. As an inhibitor of CYP17A1, the selectivity of TAK 700 is important to avoid causing the drugdrug interactions